FAKTOR-OPTIONSSCHEIN - QUEST DIAGNOSTICS | Market Closed - Börse Stuttgart 03:53:32 2024-06-06 pm EDT | ||
| 8.06 EUR | +0.50% |
|
| Current month | -3.82% | ||
| 1 month | -14.98% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about QUEST DIAGNOSTICS INCORPORATED
More news
| Date | Price | Change |
|---|---|---|
| 24-06-06 | 8.06 | +0.50% |
| 24-06-05 | 8.02 | -2.31% |
| 24-06-04 | 8.21 | -1.08% |
| 24-06-03 | 8.3 | -0.95% |
| 24-05-31 | 8.38 | -5.10% |
Delayed Quote Börse Stuttgart
Last update June 06, 2024 at 03:53 pm EDT
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | QUEST DIAGNOSTICS INCORPORATED |
| Issuer | Morgan Stanley |
| WKN | MG3D86 |
| ISIN | DE000MG3D866 |
| Date issued | 2024-04-30 |
| Strike | 190.2 $ |
| Maturity | Unlimited |
| Parity | 5.45 : 1 |
| Emission price | 10 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 9.58 € |
|---|---|
| Lowest since issue | 7.66 € |
| Spread | 0.04 € |
| Spread % | 0.49% |
Company Profile
Quest Diagnostics is the world's leading provider of diagnostics testing and information service for patients and health professionals. Net sales break down by activity as follows:
- testing and diagnostic services (97.3%): routine clinical testing, gene-based testing and advanced diagnostic and anatomica pathology diagnostic services;
- other (2.7%).
Sector
-
Ratings for Quest Diagnostics Incorporated
Trading Rating
Investor Rating
ESG Refinitiv
A-
Consensus: Quest Diagnostics Incorporated
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
142.6
USD
Average target price
147
USD
Spread / Average Target
+3.06%
- Stock Market
- Certificates
- Certificat
